Table 4.
Antecedent (T−2) cytology and HPV co-testing results that occurred before symptoms for 171 cases of endometrial cancer diagnosed (T0) with an index (T−1) co-test result of high-grade cytology or non-cervical (other) cytology that occurred after symptoms. The mean, median, and range of times between the index (T−1) co-test and EC diagnosis (T0) for these cases were 9–505, 63, and 40 days, respectively. The mean, median, and range of times between the antecedent (T−2) co-test and EC diagnosis (T0) were 83–3,780, 1,306, and 1,177 days, respectively. The mean, median, and range of times between the antecedent (T−2) co-test and index (T−1) co-test were 46–3,737, 1,244, and 1,114 days, respectively.
| Co-Testing Results | Type 1 | Type 2 | Total | ||||
|---|---|---|---|---|---|---|---|
| Cytology | HPV | N | % | N | % | N | % |
| NILM | Missing | 4 | 3.74% | 2 | 3.13% | 6 | 3.51% |
| NILM | Negative | 97 | 90.64% | 61 | 95.31% | 158 | 92.40% |
| ASC-US | Negative | 2 | 1.87% | 0 | 0.00% | 2 | 1.17% |
| AGC | Negative | 0 | 0.00% | 1 | 1.56% | 1 | 0.58% |
| NILM | Positive | 3 | 2.80% | 0 | 0.00% | 3 | 1.75% |
| LSIL | Positive | 1 | 0.93% | 0 | 0.00% | 1 | 0.58% |
| Total | 107 | 100.0% | 64 | 100.0% | 171 | 100.0% | |